Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1996
11/12/1996US5574013 Appetite suppressant, anxiolytic, antiulcer, drug withdrawal, analgesic
11/12/1996US5574011 Compositions and methods for the treatment of male-pattern baldness
11/12/1996US5574010 Treatment of pancreatic tumors with peptide YY and analogs thereof
11/12/1996US5574009 With peptides bindable with the reovirus type 3 receptor present on the surface of oligodendrocytes
11/12/1996US5574008 Antidiabetic agents
11/12/1996US5574006 Nasally administrable peptide compositions on hydroxyapatite carriers
11/12/1996US5573944 Yeast cell expressing heterologous receptor kinase
11/12/1996US5573943 Cloning and expression of a rhoptry associated protein of P. falciparum
11/12/1996US5573940 Cells expressing high levels of CD59
11/12/1996US5573939 DNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cells
11/12/1996US5573934 Photopolymerization of acrylated resin, initiator
11/12/1996US5573930 DNA encoding various forms of colony stimulating factor-1
11/12/1996US5573929 Escherichia transformed with expression vector
11/12/1996US5573925 P53 proteins with altered tetramerization domains
11/12/1996US5573910 Alginate production
11/12/1996US5573780 Stable solid formulation of enalapril salt and process for preparation thereof
11/12/1996US5573775 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
11/12/1996US5573767 Lutenizing hormone-releasing hormone
11/12/1996US5573764 Use of interleukin-12 to prevent graft versus host disease
11/12/1996US5573763 Family of CSF-l proteins
11/12/1996US5573762 Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
11/12/1996US5573758 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
11/12/1996CA2068438C Essential pure human parathyroid hormone
11/12/1996CA1338720C Derivative of human growth hormone
11/12/1996CA1338707C Protein h being capable of binding to igg, gene coding for the said protein h and a process for producing the said protein h
11/12/1996CA1338699C Modified tpa-containing injection composition
11/12/1996CA1338698C Process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine
11/11/1996CA2175985A1 Pharmaceutical composition containing substance inhibiting hsp47 production
11/07/1996WO1996034974A1 Low oxygen affinity mutant hemoglobin
11/07/1996WO1996034969A2 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996WO1996034966A2 Engineering protein posttranslational modification in transgenic organisms
11/07/1996WO1996034965A2 Chimeric mcp and daf proteins with cell surface localizing domain
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034959A1 Aluminium resistance gene
11/07/1996WO1996034957A1 Pancreas-derived serpin
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034955A1 Method of treating cartilaginous diseases with genetically modified chondrocytes
11/07/1996WO1996034953A2 Cd16-ii variants
11/07/1996WO1996034952A1 Expression of tap and lmp in tumour cells
11/07/1996WO1996034950A1 E6ap antisense constructs and methods of use
11/07/1996WO1996034948A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
11/07/1996WO1996034947A1 Method for activating prothrombin to thrombin
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034941A1 Use of extracellular cysteine protease to inhibit cell proliferation
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034892A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034890A2 Inhibitors of fibrin cross-linking and/or transglutaminases
11/07/1996WO1996034889A1 Storage stable hemoglobin solutions
11/07/1996WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity
11/07/1996WO1996034887A2 Antisense peptides
11/07/1996WO1996034886A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
11/07/1996WO1996034885A2 Biologically active peptide fragments of ob protein
11/07/1996WO1996034884A2 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
11/07/1996WO1996034882A1 Single chain insulin with high bioactivity
11/07/1996WO1996034881A1 Peptide compositions with growth factor-like activity
11/07/1996WO1996034880A1 Cd6 ligand
11/07/1996WO1996034877A1 Human neuropeptide receptor
11/07/1996WO1996034873A1 Recombinant endotoxin-neutralizing proteins
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996WO1996034627A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996WO1996034622A1 Modified myelin protein molecules
11/07/1996WO1996034620A1 Restoration of progenitor cells after antiproliferative therapy treatments
11/07/1996WO1996034619A1 Methods of preventing neuron degeneration and promoting neuron regeneration
11/07/1996WO1996034618A1 Tissue adhesive using synthetic cross-linking
11/07/1996WO1996034617A1 COMPOUNDS THAT BIND TO p185 AND METHODS OF USING THE SAME
11/07/1996WO1996034616A1 Serum preparations for inhibiting retroviruses and tumor growth
11/07/1996WO1996034615A1 Method for soft-tissue augmentation
11/07/1996WO1996034614A1 Method of preventing or treating alimentary tract damage due to chemotherapy or radiation
11/07/1996WO1996034612A1 Compositions for the treatment of infections caused by hiv, aids and lymphomas using hydrogen peroxide
11/07/1996WO1996034602A1 Methods of inhibition or killing of cancer cells
11/07/1996WO1996034596A2 Use of emu oil for stimulating skin and hair growth
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996WO1996027369A3 Compositions for the treatment of blood disorders
11/07/1996WO1996022379A3 Direct gene transfer into the ruminant mammary gland
11/07/1996CA2223272A1 Single chain insulin with high bioactivity
11/07/1996CA2220268A1 Inhibitors of fibrin cross-linking and/or transglutaminases
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220098A1 Cd6 ligand
11/07/1996CA2220036A1 Human neuropeptide receptor
11/07/1996CA2219899A1 Shark serum preparations for inhibiting retroviruses and tumor growth
11/07/1996CA2219775A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996CA2219020A1 Tissue adhesive using synthetic cross-linking
11/07/1996CA2218858A1 Modified myelin protein molecules
11/07/1996CA2218390A1 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996CA2218034A1 Pancreas-derived serpin
11/07/1996CA2216382A1 Storage stable hemoglobin solutions
11/06/1996EP0741188A2 Single chain insulin with high bioactivity
11/06/1996EP0741187A2 Recombinant obese (Ob) proteins
11/06/1996EP0741143A2 Fibroblast growth factor fragments
11/06/1996EP0741142A1 Peptide and antithrombotic agent
11/06/1996EP0740940A2 Process for disinfecting musculoskeletal tissue and tissues prepared thereby
11/06/1996EP0740939A1 Compositions for treatment and prophylaxis of atherosclerosis
11/06/1996EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci
11/06/1996EP0740702A1 Novel human amyloid protein precursor homologue and kunitz-type inhibitors
1 ... 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 ... 3163